LPTX icon

Leap Therapeutics
LPTX

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $700K invested in Leap Therapeutics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$213K
2
+$126K
3
+$84K
4
UBS Group
UBS Group
Switzerland
+$7K

Top Sellers

1
-$184K
2
-$3.27K
3
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$213K
2
$211K
3
$126K
4
$84K
5
$57K
6
$7K
7
$1K
8
$1K
9
–
10
–